ProShare Advisors LLC - Q4 2019 holdings

$21.6 Billion is the total value of ProShare Advisors LLC's 1787 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 100.0% .

 Value Shares↓ Weighting
CVRS ExitCORINDUS VASCULAR ROBOTICS I$0-10,461
-100.0%
0.00%
DFODQ ExitDEAN FOODS CO NEW$0-11,879
-100.0%
0.00%
TNK ExitTEEKAY TANKERS LTDcl a$0-21,696
-100.0%
0.00%
FPRX ExitFIVE PRIME THERAPEUTICS INC$0-13,884
-100.0%
0.00%
ABUS ExitARBUTUS BIOPHARMA CORP$0-15,394
-100.0%
0.00%
ADRO ExitADURO BIOTECH INC$0-29,154
-100.0%
0.00%
OCUL ExitOCULAR THERAPEUTIX INC$0-17,500
-100.0%
0.00%
PRTK ExitPARATEK PHARMACEUTICALS INC$0-12,454
-100.0%
0.00%
ASNA ExitASCENA RETAIL GROUP INC$0-18,286
-100.0%
0.00%
ASRT ExitASSERTIO THERAPEUTICS INC$0-26,527
-100.0%
0.00%
ADAP ExitADAPTIMMUNE THERAPEUTICS PLCsponds adr$0-22,483
-100.0%
0.00%
CLVS ExitCLOVIS ONCOLOGY INC$0-20,532
-100.0%
0.00%
ADMS ExitADAMAS PHARMACEUTICALS INC$0-10,090
-100.0%
0.00%
SYBX ExitSYNLOGIC INC$0-10,377
-100.0%
0.00%
ACRS ExitACLARIS THERAPEUTICS INC$0-14,710
-100.0%
0.00%
ELOX ExitELOXX PHARMACEUTICALS INC$0-13,680
-100.0%
0.00%
KALA ExitKALA PHARMACEUTICALS INC$0-11,695
-100.0%
0.00%
VSTM ExitVERASTEM INC$0-20,070
-100.0%
0.00%
ACOR ExitACORDA THERAPEUTICS INC$0-19,354
-100.0%
0.00%
PTI ExitPROTEOSTASIS THERAPEUTICS IN$0-13,845
-100.0%
0.00%
ZFGN ExitZAFGEN INC$0-10,115
-100.0%
0.00%
AGLE ExitAEGLEA BIOTHERAPEUTICS INC$0-10,801
-100.0%
0.00%
SBBP ExitSTRONGBRIDGE BIOPHARMA PLC$0-18,794
-100.0%
0.00%
TRXC ExitTRANSENTERIX INC$0-20,965
-100.0%
0.00%
SVRA ExitSAVARA INC$0-15,106
-100.0%
0.00%
POLY ExitPLANTRONICS INC NEW$0-6,333
-100.0%
-0.00%
DOVA ExitDOVA PHARMACEUTICALS INC$0-8,744
-100.0%
-0.00%
GCI ExitGANNETT CO INC$0-15,042
-100.0%
-0.00%
MNOV ExitMEDICINOVA INC$0-16,426
-100.0%
-0.00%
CRZO ExitCARRIZO OIL & GAS INC$0-12,468
-100.0%
-0.00%
NERV ExitMINERVA NEUROSCIENCES INC$0-13,935
-100.0%
-0.00%
TORC ExitRESTORBIO INC$0-11,557
-100.0%
-0.00%
OI ExitOWENS ILL INC$0-12,464
-100.0%
-0.00%
PETQ ExitPETIQ INC$0-8,431
-100.0%
-0.00%
XERS ExitXERIS PHARMACEUTICALS INC$0-10,344
-100.0%
-0.00%
AVRO ExitAVROBIO INC$0-10,919
-100.0%
-0.00%
ANAB ExitANAPTYSBIO INC$0-10,120
-100.0%
-0.00%
BID ExitSOTHEBYS$0-6,199
-100.0%
-0.00%
LTXB ExitLEGACY TEX FINL GROUP INC$0-6,721
-100.0%
-0.00%
CBM ExitCAMBREX CORP$0-4,690
-100.0%
-0.00%
CMPR ExitCIMPRESS N V$0-2,472
-100.0%
-0.00%
ALDR ExitALDER BIOPHARMACEUTICALS INC$0-30,949
-100.0%
-0.00%
GWR ExitGENESEE & WYO INCcl a$0-4,516
-100.0%
-0.00%
MDSO ExitMEDIDATA SOLUTIONS INC$0-7,609
-100.0%
-0.00%
GHDX ExitGENOMIC HEALTH INC$0-13,694
-100.0%
-0.01%
VSM ExitVERSUM MATLS INC$0-19,306
-100.0%
-0.01%
ONCE ExitSPARK THERAPEUTICS INC$0-14,334
-100.0%
-0.01%
CBS ExitCBS CORP NEWcl b$0-60,632
-100.0%
-0.01%
VIAB ExitVIACOM INC NEWcl b$0-137,629
-100.0%
-0.02%
HCP ExitHCP INC$0-191,539
-100.0%
-0.04%
CTRP ExitCTRIP COM INTL LTDsponsored ads$0-285,838
-100.0%
-0.05%
BBT ExitBB&T CORP$0-183,142
-100.0%
-0.06%
STI ExitSUNTRUST BKS INC$0-142,382
-100.0%
-0.06%
ISCA ExitINTERNATIONAL SPEEDWAY CORPcl a$0-249,887
-100.0%
-0.06%
CTWS ExitCONNECTICUT WTR SVC INC$0-159,435
-100.0%
-0.06%
SYMC ExitSYMANTEC CORP$0-532,345
-100.0%
-0.07%
CELG ExitCELGENE CORP$0-704,513
-100.0%
-0.39%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-02-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
APPLE INC42Q3 20237.4%
MICROSOFT CORP42Q3 20236.5%
AMAZON COM INC42Q3 20235.3%
META PLATFORMS INC42Q3 20232.8%
EXXON MOBIL CORP42Q3 20231.8%
INTEL CORP42Q3 20231.4%
JOHNSON & JOHNSON42Q3 20231.3%
PEPSICO INC42Q3 20231.4%
CHEVRON CORP NEW42Q3 20231.3%
CISCO SYS INC42Q3 20231.2%

View ProShare Advisors LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-08
13F-HR2024-02-14
13F-HR2023-11-13
13F-HR2023-08-10
13F-HR/A2023-05-26
13F-HR2023-05-12
13F-HR2023-02-02
SC 13G/A2023-01-26
13F-HR2022-11-07
13F-HR2022-08-01

View ProShare Advisors LLC's complete filings history.

Compare quarters

Export ProShare Advisors LLC's holdings